Aportaciones congreso (1) Publicaciones en las que ha participado algún/a investigador/a

2021

  1. Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC

    Journal of Thoracic Oncology